Precise Neoadjuvant Chemoresection of Low Grade NMIBC

Conditions: Bladder Cancer; Non-muscle Invasive Bladder Cancer; Low-risk Interventions: Drug: Epirubicin; Drug: Mitomycin; Drug: Gemcitabine; Drug: Docetaxel Sponsors: University of Bern; Spitalzentrum Biel Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials